Screener
10x Genomics, Inc. TXG Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 132,052 | 94,958 | 255,276 | 239,731 |
| Income (loss) from operations | (19,555) | 30,126 | (36,601) | (9,202) |
| Other income (expense): | ||||
| Interest income | 4,797 | 4,271 | 9,811 | 7,957 |
| Interest expense | — | (3) | — | (3) |
| Other income (expense), net | (3,887) | 2,603 | (4,702) | 4,739 |
| Total other income | 910 | 6,871 | 5,109 | 12,693 |
| Income (loss) before provision for income taxes | (18,645) | 36,997 | (31,492) | 3,491 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s interest income?
- 10x Genomics, Inc. (TXG) reported interest income of $4.8M in Q2 2026.
- How has 10x Genomics, Inc.'s interest income changed year-over-year?
- 10x Genomics, Inc.'s interest income increased by 12.3% year-over-year, from $4.27M to $4.8M.
- What is the long-term trend for 10x Genomics, Inc.'s interest income?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s interest income has grown at a 214.1% compound annual growth rate (CAGR), from $206K to $20.05M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about 10x Genomics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude